secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2024-10-16T23:59:59+00:00
Accession:  0001232524-24-000073
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Jazz Pharma ends Palo Alto lease early, signs new lease nearby
--------------------------------------------------------------

- Existing lease at 3170 Porter Drive terminated effective June 30, 2025 (original expiry Oct 2029).
- Landlord secured replacement tenant; Jazz will pay a lease modification payment.
- New lease executed Oct 11, 2024 for 3000 El Camino Real, Palo Alto; occupancy by July 1, 2025.
- Jazz continues U.S. operations in Palo Alto, Carlsbad, CA and Philadelphia, PA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000123252424000073/0001232524-24-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000123252424000073/jazz-20241010.htm
  HTML page:      https://secwatch.observer/filing/0001232524-24-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer